… responses in the refractory setting by PD-1/-L1 +/- CTLA 4 inhibition. Thus, ongoing phase 3
trials in this subgroup evaluate immunotherapy … immunotherapeutic agents (eg CEA-TCB). …

… -stage colon cancer. The … response to immunotherapy. Concurrently, the NICHE-2 study,21
conducted as a follow-up, encompassed 112 patients diagnosed with dMMR colon cancer. …

… However, the independent application of TMB for the prediction of immunotherapy
response in colon cancer is still controversial. In the KEYNOTE 177 trial, the limits of TMB as a …

… of neoadjuvant immunotherapy compared … response to neoadjuvant chemotherapy in dMMR
tumors in the FOXTROT study, and the 100% response rate to neoadjuvant immunotherapy …

PURPOSE The purpose of this study was to evaluate the prognostic value of Immunoscore
in patients with stage III colon cancer (CC) and to analyze its association with the effect of …

… and adaptive immune response within colorectal cancer supports the … colon cancer also
result in the expression of numerous mutant epitopes that may be targets of immune responses […

… been used to evaluate the serological response of 74 colon cancer patients and 75 normal
… a colon cancer-related serological response and altered mRNA expression in colon cancer. …

… immune response was analyzed. Finally, we predicted the immunotherapeutic response rates
… BGN expression presented a better immunotherapeutic response in colon cancer patients. …

… colon cancer tumorigenesis. However, the connection between APC gene mutation and
immunotherapy efficacy for colon cancer … mutation on immunotherapy efficacy for colon cancer. …

… Our efforts have focused on active specific immunotherapy (ASI) that makes use of the patient's
tumour to elicit a long-term cell-mediated immune response as adjuvant therapy. Clinical …